Bursitis Treatment Market Growth: Study in Detail about the Global Market Analysis along with Top Companies

Bursitis is a swelling or inflammation of the bursa – a sac filled with a lubricating fluid and located between the tissues such as bone, skin, tendons and muscles. Lubricating fluid helps in reducing the friction, rubbing and irritation upon movement of a joint. Bursitis affects mainly elbow, hip, shoulder, knee and Achilles tendon. The most common symptoms of bursitis are pain, swelling and stiffness in affected area. Sudden or severe pain may gradually build up, if there is a presence of calcium deposits. Bursitis is commonly caused by the repetitive trauma of injuries on the affected area. Improper posture at home, work and poor stretching before exercise also lead to bursitis. A poorly or an abnormal placed bone or joint can put extra stress on a bursa sac, causing bursitis. Infection from other conditions such as thyroid disorder gout, or unusual medication reactions also increase a person’s risk for bursitis. Sometimes an infection can sometimes lead to inflammation of a bursa. In adults bursitis is very common especially those over 40 years of age. There are number of ways for bursitis treatment like resting the injured area, icing the area, avoiding activities that aggravate the problem, taking over the counter anti-inflammatory medicines and many more. Surgery may be an option when bursitis does not respond to the other treatment options but it is rarely needed.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/18394

The global bursitis treatment market is driven by the increasing geriatric population highly prone to the bone injury. Another factor which can influence the growth of global bursitis market can be rising number of sports related injuries. Moreover, increasing incidence of elbow joint pain and R&D investment by pharmaceutical companies etc. are the factors which are driving the global bursitis market. However, lack of awareness towards bursitis treatment options, low treatment rate due to absence of signs and symptoms of bursitis are some factors limiting the growth of global bursitis treatment market.

Based on treatment type, the global bursitis treatment market is segmented into corticosteroids, antibiotic, Analgesics and others. Based on route of administration, the global bursitis treatment market is segmented into oral and tropical. Generally the tropical medications are prescribed as they can be directly applied to the affected area and provide early relief of symptoms. Based on distribution channel, the global bursitis treatment market is segmented into, hospital pharmacies, retail pharmacies, online pharmacies and drug stores. Hospital pharmacies segment is expected to hold maximum share in the market due to the increase in prescription of anti-inflammatory drugs for bursitis treatment.

Geographically, the global bursitis treatment market has been segmented into regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region is expected to remain dominant market for bursitis treatment due to a large number of established research organizations, advanced health care facilities and ongoing clinical researches on bursitis treatment. Europe region is expected to be the second largest bursitis treatment market due to easy availability of reimbursement. Asia Pacific bursitis market is expected to grow at considerable rate due to increasing healthcare spending and rise in disposable income.

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/toc/18394

Some of the key players identified in the global bursitis treatment market are Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Crecent Therapeutics Limited, Arinna Lifesciences Private Limited, Sun Pharmaceutical Industries Ltd., Cipla Inc, LUPIN Limited, Bioanalytical Systems, Inc. (Pfizer Inc.), Perrigo Company plc, Arbor Pharmaceuticals Inc. etc. among others.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.